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Abstract
The apelin receptor (nomenclature as agreed by the NC-IUPHAR Subcommittee on the apelin receptor
[68]) responds to apelin, a 36 amino-acid peptide derived initially from bovine stomach. apelin-36, apelin-13 and
[Pyr1]apelin-13 are the predominant endogenous ligands which are cleaved from a 77 amino-acid precursor
peptide (APLN, Q9ULZ1) by a so far unidentified enzymatic pathway [80]. A second family of peptides
discovered independently and named Elabela [11] or Toddler, that has little sequence similarity to apelin, is
present, and functional at the apelin receptor in the adult cardiovascular system [87, 67]. Structure-activity
relationship Elabela analogues have been described [61].
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